25 May 2013
Keywords: basilea, eczema, drug, uk, price, twice, estimate
Article | 15 September 2008
Basel, Switzerland-based firm Basilea Pharmaceutica has received the first marketing authorization in the UK for its Toctino (alitretinoin)
oral treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 September 2008
24 May 2013
© 2013 thepharmaletter.com